Histopathology of keratoacanthoma revisited: Utility of orificial size as a diagnostic adjunct

International Journal of Surgical Pathology

Volumn 22, Issue 4, 2014, Pages 316-325

  Aung, Phyu P ^a   Ballester, Leomar Y ^b   Mahalingam, Meera ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Keratoacanthoma (KA); Orificial size

Indexed keywords

ABSCESS; ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER DIAGNOSIS; CROSS-SECTIONAL STUDY; CUTANEOUS PARAMETERS; ELASTIC FIBER; FEMALE; FIBROSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KERATINOCYTE; KERATOACANTHOMA; KERATOTIC PAPULE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEUTROPHILIC ABSCESS; ONCOLOGICAL PARAMETERS; ORIFICIAL SIZE; PAPULE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX RATIO; TUMOR BIOPSY; VERY ELDERLY; SKIN DISEASES;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; KERATOACANTHOMA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SKIN DISEASES;

EID: 84904131746     PISSN: 10668969     EISSN: 19402465     Source Type: Journal    
DOI: 10.1177/1066896913509010     Document Type: Article

References (37)

1. Weedon D. Keratoacanthoma: A personal perspective. Curr Diagn Pathol. 2003;9:259-265 (Pubitemid 36759400)
2. Chuang TY, Reizner GT, Elpern DJ, Stone JL, Farmer ER. Keratoacanthoma in Kauai, Hawaii. The first documented incidence in a defined population. Arch Dermatol. 1993;129:317-319 (Pubitemid 23077446)
3. Kong HH, Cowen EW, Asad NS, Dahut W, Gutierrez M, Turner ML. Keratoacanthomas associated with sorafenib therapy. J Am Acad Dermatol. 2007;56:171-172
4. Esser AC, Abril A, Fayne S, Doyle JA. Acute development of multiple keratoacanthomas and squamous cell carcinomas after treatment with infliximab. J Am Acad Dermatol. 2004;50:S75-S77 (Pubitemid 38580526)
5. Staples MP, Elwood M, Burton RC, Williams JL, Marks R, Giles GG. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust. 2006;184:6-10 (Pubitemid 43149790)
6. Veness MJ. High-risk cutaneous squamous cell carcinoma of the head and neck. J Biomed Biotechnol. 2007;80:572-578
7. Ko CJ, McNiff JM, Bosenberg M, Choate KA. Keratoacanthoma: clinical and histopathologic features of regression. J Am Acad Dermatol. 2012;67:1008-1012
8. Tas E, Birol Ugur M, Gul A, Cinar F, Uzun L, Dogan Gun B. A misdiagnosed keratoacanthoma turned out to be a metastatic parotid carcinoma. Acta Otorhinolaryngol Ital. 2010;30:115-117
9. Godbolt AM, Sullivan JJ, Weedon D. Keratoacanthoma with perineural invasion: A report of 40 cases. Australas J Dermatol. 2001;42:168-171 (Pubitemid 32721555)
10. Schnur PL, Bozzo P. Metastasizing keratoacanthomas? The difficulties in differentiating keratoacanthomas from squamous cell carcinomas. Plast Reconstr Surg. 1978;62:258-262 (Pubitemid 9037630)
11. Jackson IT. Diagnostic problem of keratoacanthoma. Lancet. 1969;1:490-492
12. Petter G, Haustein UF. Squamous cell carcinoma of the skin - histopathological features and their significance for the clinical outcome. J Eur Acad Dermatol Venereol. 1998;11:37-44 (Pubitemid 28383613)
13. Roozeboom MH, Lohman BG, Westers-Attema A, et al. Clinical and histological prognostic factors for local recurrence and metastasis of cutaneous squamous cell carcinoma: Analysis of a defined population. Acta Derm Venereol. 2013;93:417-421
14. Fisher ER, McCoy MM, Wechsler HL. Analysis of histopathologic and electron microscopic determinants of keratoacanthoma and squamous cell carcinoma. Cancer. 1972;29:1387-1397
15. Ackerman AB, Ragaz A. Keratoacanthoma. In: The Lives of Lesions: Chronology in Dermatology. New York, NY: Masson; 1984:102-109
16. Cribier B, Asch PH, Grosshans E. Differentiating squamous cell carcinoma from keratoacanthoma using histopathological criteria. Is it possible? A study of 296 cases. Dermatology. 1999;199:208-212
17. Kossard S, Tan KB, Choy C. Keratoacanthoma and infundibulocystic squamous cell carcinoma. Am J Dermatopathol. 2008;30:127-134 (Pubitemid 351441984)
18. Smoller BR, Kwan TH, Said JW, Banks-Schlegel S. Keratoacanthoma and squamous cell carcinoma of the skin. Immunohistochemical localization of involucrin and keratin proteins. J Am Acad Dermatol. 1986;14:226-234
19. Suo Z, Holm R, Nesland JM. Squamous cell carcinomas. An immunohistochemical study of cytokeratins and involucrin in primary and metastatic tumours. Histopathology. 1993;23:45-54 (Pubitemid 23233251)
20. Kannon G, Park HK. Utility of peanut agglutinin (PNA) in the diagnosis of squamous cell carcinoma and keratoacanthoma. Am J Dermatopathol. 1990;12:31-36 (Pubitemid 20060400)
21. Asch PH, Basset P, Roos M, Grosshans E, Bellocq JP, Cribier B. Expression of stromelysin 3 in keratoacanthoma and squamous cell carcinoma. Am J Dermatopathol. 1999;21:146-150 (Pubitemid 29162873)
22. Jordan RCK, Kahn HJ, From L, Jambrosic J. Immunohistochemical demonstration of actinically damaged elastic fibers in keratoacanthomas: An aid in diagnosis. J Cutan Pathol. 1991;18:81-86
23. Airola K, Johansson N, Kariniemi AL, Kähäri VM, Saarialho-Kere UK. Human collagenase-3 is expressed in malignant squamous epithelium of the skin. J Invest Dermatol. 1997;109:225-231 (Pubitemid 27337340)
24. Ahmed NU, Ueda M, Ichihashi M. p21WAF1/CIP1 expression in non-melanoma skin tumors. J Cutan Pathol. 1997;24:223-227 (Pubitemid 27187018)
25. Ahmed NU, Ueda M, Ichihashi M. Increased levels of c-erbB-2/neu/HER-2 protein in cutaneous squamous cell carcinoma. Br J Dermatol. 1997;136:908-912 (Pubitemid 27283523)
26. Papadavid E, Pignatelli M, Zakynthinos S, Krausz T, Chu AC. The potential role of abnormal E-cadherin and α-, β- and γ-catenin immunoreactivity in the determination of the biological behaviour of keratoacanthoma. Br J Dermatol. 2001;145:582-589
27. Slater M, Barden JA. Differentiating keratoacanthoma from squamous cell carcinoma by the use of apoptotic and cell adhesion markers. Histopathology. 2005;47:170-178 (Pubitemid 41113120)
28. Phillips P, Helm KF. Proliferating cell nuclear antigen distribution in keratoacanthoma and squamous cell carcinoma. J Cutan Pathol. 1993;20:424-428 (Pubitemid 23332280)
29. Cain CT, Niemann TH, Argenyi ZB. Keratoacanthoma versus squamous cell carcinoma. An immunohistochemical reappraisal of p53 protein and proliferating cell nuclear antigen expression in keratoacanthoma-like tumors. Am J Dermatopathol. 1995;17:324-331
30. Bergman R, Amichai B, Kilim S, et al. An immunohistochemical study of bcl-2 protein expression in keratoacanthoma, as compared to squamous cell carcinoma and basal cell carcinoma. Am J Dermatopathol. 1997;19:506
31. Kaabipour E, Haupt HM, Stern JB, Kanetsky PA, Podolski VF, Martin AM. p16 expression in keratoacanthomas and squamous cell carcinomas of the skin. An immunohistochemical study. Arch Pathol Lab Med. 2006;130:69-73 (Pubitemid 43077238)
32. Kerschmann RL, McCalmont TH, LeBoit PE. p53 oncoprotein expression and proliferation index in keratoacanthoma and squamous cell carcinoma. Arch Dermatol. 1994;130:181-186
33. Pilch H, Weiss J, Heubner C, Heine M. Differential diagnosis of keratoacanthomas and squamous cell carcinomas: diagnostic value of DNA image cytometry and p53 expression. J Cutan Pathol. 1994;21:507-513
34. Waring AJ, Takata M, Rehman I, Rees JL. Loss of heterozygosity analysis of keratoacanthoma reveals multiple differences from cutaneous squamous cell carcinoma. Br J Cancer. 1996;73:649-653 (Pubitemid 26068872)
35. Binder M, Steiner A, Mossbacher U, Hunegnaw M, Pehamberger H, Wolff K. Estimation of the volumeweighted mean nuclear volume discriminates keratoacanthoma from squamous cell carcinoma. Am J Dermatopathol. 1998;20:453-458 (Pubitemid 28463410)
36. Kanekura T, Yonekura K, Yoshii N. Increased glucose uptake by keratoacanthoma detected by positron emission tomography. Clin Exp Dermatol. 2007;32:581-582 (Pubitemid 47231134)
37. Sánchez Yus E, Simón P, Requena L, Ambrojo P, de Eusebio E. Solitary keratoacanthoma: A self-healing proliferation that frequently becomes malignant. Am J Dermatopathol. 2000;22:305-310. (Pubitemid 30618611)